Impact of oestrogens on the progression of liver disease.
about
Endocrine causes of nonalcoholic fatty liver diseaseHepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and ManagementHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverPrior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasmaDehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptorNeonatal androgenization exacerbates alcohol-induced liver injury in adult rats, an effect abrogated by estrogen.Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese populationFemale hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.Changes of ECM and CAM gene expression profile in the cirrhotic liver after HCV infection: analysis by cDNA expression arraySex differences in inflammatory cytokine production in hepatic ischemia-reperfusion.Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells.Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analoguesLiver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury.Lentivirus-Mediated siRNA Targeting ER-α Inhibits Tumorigenesis and Induces Apoptosis in Hepatocarcinoma Cells.Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development.Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosisThe Value of U/S to Determine Priority for Upper Gastrointestinal Endoscopy in Emergency Room.Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis CGender-based outcomes differences in unresectable hepatocellular carcinoma.Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.Role of estrogen in hepatocellular carcinoma: is inflammation the key?Clinical penetrance of C282Y homozygous HFE hemochromatosis.Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?Review article: the management of cirrhosis in women.The stellate cell system (vitamin A-storing cell system).Relation between sex hormones and hepatocellular carcinoma.Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population.Effects of pharmacological serum from normal and liver fibrotic rats on HSCs.MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol.Apocynin reduced doxycycline-induced acute liver injury in ovariectomized mice.Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C.Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects.Natural history and management of hepatitis C: does sex play a role?
P2860
Q26780254-6FC7CA43-AF57-4526-ACC8-F65B983EAC5FQ26781984-BE68CCDF-28C5-4726-A60F-975A5253F53CQ29616840-745C4AB0-31A3-49E6-9455-A94B58F80318Q30881190-81C148C4-19EE-420F-A90E-B052B89D2A68Q30990299-055691BC-D6B1-4AA6-957A-435157A49481Q33820667-3323173F-75D3-419F-998A-AF69F5F0B7E1Q34113751-D4D9BFC8-CD29-4A18-A21E-0CF95206EB95Q34315221-C5B14780-0E14-4F43-978C-512AB95DFAF6Q34606036-59A26890-1C3F-49E9-AD3A-12B87E05F40CQ35010783-B9902D22-DFA7-4BA3-A939-034B8BE5B039Q35574175-284B7C4E-9736-48C6-81AC-B1ED67CE8E34Q35598020-386EECBF-C34D-4842-8766-DE4BFCC04696Q35668307-3E08A4D9-4901-4424-B6F9-68983EFFB6D0Q35668724-8AE3818A-7B72-46A8-92A7-5EA77D66AEAFQ35761351-9F604A56-FF8B-42CC-A62C-11996D3593C9Q35885451-43F65AED-033E-4B0D-A215-290B37877A15Q35922580-578CA77F-4E3E-46C4-AF35-4CC295B2C890Q36043477-B7B3E063-6BBE-4484-BAF9-EC3168A81869Q36373621-15FB755F-D53B-4F62-BA61-39C2FCB17B0EQ36544261-07EEA232-4A10-40CE-B364-9F072F135236Q36875004-2213B779-2927-4942-9E8F-11D86F2C0C8AQ37226053-A2A7F3CF-81D0-40C9-8B31-5059C9E40B47Q37245488-B060FDC0-4D42-4EA2-8803-1223FB6F015BQ37278203-1354CD5F-F77C-4BA6-B734-38EEDE79ACFFQ37302943-09BFDB3F-769F-4167-A34E-F7517BEAC524Q37312786-91CCFA21-C125-42B1-9873-51BADE27DDF2Q37710885-E44323C6-3F77-4C50-A37F-102082765A76Q37810066-0D2CB38D-E368-4C68-9AC0-E98521ADC148Q38174255-4FB446BF-29D5-49E2-BDC1-D9E5EE0B6F96Q38255043-B603B540-C611-4B9A-844E-4561F63AF98FQ38744473-55EABE0A-90FB-4947-81E0-BE9321F6B298Q38985066-F8062154-CE6D-44E2-92B2-0511B1950351Q40173544-F8BA0567-4EC1-44F6-B3F5-CDB205362929Q40277965-E9D93EF8-4785-44AA-92BB-089BE8643461Q40434834-01DF1633-B058-489C-89D5-F2B48D468A3CQ41504596-65846D85-8FB4-485D-A32C-17BDB9D61694Q41679559-98DA7142-E3E8-43C3-9635-F1EB78BB0443Q42150842-44F78FF9-DCB4-4F0F-AC1F-12434A986F4AQ42182106-C7690B23-0338-47E5-B545-2CADF8ADF565Q42208880-C919AFD1-213A-421C-BA8B-C75EA5DF96D0
P2860
Impact of oestrogens on the progression of liver disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Impact of oestrogens on the progression of liver disease.
@ast
Impact of oestrogens on the progression of liver disease.
@en
type
label
Impact of oestrogens on the progression of liver disease.
@ast
Impact of oestrogens on the progression of liver disease.
@en
prefLabel
Impact of oestrogens on the progression of liver disease.
@ast
Impact of oestrogens on the progression of liver disease.
@en
P2860
P1433
P1476
Impact of oestrogens on the progression of liver disease.
@en
P2093
Ichiro Shimizu
P2860
P356
10.1034/J.1600-0676.2003.00811.X
P577
2003-02-01T00:00:00Z